Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Times Interest Earned (2018 - 2025)

Historic Times Interest Earned for Puma Biotechnology (PBYI) over the last 8 years, with Q3 2025 value amounting to $6.43.

  • Puma Biotechnology's Times Interest Earned fell 973.16% to $6.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.13, marking a year-over-year increase of 6810.27%. This contributed to the annual value of $2.49 for FY2024, which is 156.08% up from last year.
  • Puma Biotechnology's Times Interest Earned amounted to $6.43 in Q3 2025, which was down 973.16% from $3.61 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Times Interest Earned high stood at $7.12 for Q3 2024, and its period low was -$4.73 during Q2 2021.
  • Moreover, its 5-year median value for Times Interest Earned was $1.83 (2025), whereas its average is $2.03.
  • As far as peak fluctuations go, Puma Biotechnology's Times Interest Earned crashed by 35095.58% in 2021, and later soared by 175057.16% in 2022.
  • Over the past 5 years, Puma Biotechnology's Times Interest Earned (Quarter) stood at -$0.19 in 2021, then surged by 1750.57% to $3.05 in 2022, then skyrocketed by 44.44% to $4.41 in 2023, then grew by 15.57% to $5.1 in 2024, then grew by 26.08% to $6.43 in 2025.
  • Its last three reported values are $6.43 in Q3 2025, $3.61 for Q2 2025, and $1.83 during Q1 2025.